<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the progression of splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>) with circulating villous lymphocytes to Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with the presence of a t(8;14)(q24;q32) followed by a highly aggressive course </plain></SENT>
<SENT sid="1" pm="."><plain>While the initial indolent <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had an IgM lambda immunophenotype the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was IgM kappa-positive </plain></SENT>
<SENT sid="2" pm="."><plain>Immunoglobulin heavy chain gene (IGH) sequence analysis showed no identity between the two clones </plain></SENT>
<SENT sid="3" pm="."><plain>We conclude that Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> can occur in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>, although not necessarily of identical clonal origin </plain></SENT>
</text></document>